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Genome Sequence of Vaccinia virus Strain Lister-Butantan, a Lister
Vaccine Variant Used during a Smallpox Eradication Campaign in
Brazil
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Here, we report the 187.8-kb genome sequence of Vaccinia virus Lister-Butantan, which was used in Brazil during the WHO
smallpox eradication campaign. Its genome showed an average similarity of 98.18% with the original Lister isolate, highlighting
the low divergence among related Vaccinia virus vaccine strains, even after several passages in animals and cell culture.
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Among strains used in the Smallpox Eradication Programme,Lister-derived strains were by far the most widely distributed
around the world (1). Due to this, several different strains were
generated in different countries, leading ultimately to a slightly
divergent variants of the Lister Elstree original strain (LO) (2, 3).
In Brazil, some laboratories received financial support for the de-
velopment of freeze-dried vaccine production during earlier years
of the national smallpox eradication campaign (1, 4). In this work,
we report the genome sequence of vaccine Vaccinia virus strain
Lister-Butantan (LBT), a strain largely used during the national
smallpox eradication campaign in Brazil.
The LBT genome was extracted using a BioRobot EZ1 work-
station and the protocol to purify genomic DNA from tissue
(Qiagen, Hilden, Germany). The DNA was used as a template for
producing 20 overlapping PCR amplicons. The templates were
sequenced by primer walking on both strands using Applied Bio-
systems BigDye 3.1 chemistry and ABI 3730XL automated DNA
(Applied Biosystems, Coralville, IA). The resulting reads covered
the genome in a 9-fold average redundancy at each base position.
Chromatogram data were assembled using SeqMerge (Accelrys,
Inc., Madison, WI), Phred/Phrap was used for base-calling and
assembly software, and Consed was used for sequence editing. The
FgenesV tool was used for gene prediction (http://www.softberry
.com/). The functional annotations were performed using the
Blast2GO platform (5). The genome annotation was manually
revised. Predicted open reading frames (ORFs) 40 amino acids
and with no hits in any database were ruled out.
The LBT genome is a linear double-stranded DNA (dsDNA)
molecule of 187,893 bp long, with a GC content of 33.66%. This
molecule was predicted to contain 222 ORFs, with size ranging
from 40 to 1,286 amino acids (aa) (average length, 783 aa). The
LBT and LO strains showed a mean amino acid identity of 99.47%.
Moreover, we identified a total of 535 nucleotide substitutions, of
which 206 (38.5%) were nonsynonymous.
Phylogenetic analysis based on the central conserved region of
the genome (81 kbp) revealed that LBT is related to Vaccinia virus
(VV) strain Lister, commonly used in Europe during the smallpox
eradication program (6).
Regarding main differences between the LBT and LO strains,
we highlight the single nucleotide polymorphisms (SNPs) and/or
other kinds of polymorphisms in genes involved in: (i) evasion of
host defense mechanisms or virulence: ORF 013 (serine protease
inhibitor [SPI-1]), ORF 019 (interleukin 18 [IL-18] binding pro-
tein), M2L and K1L genes (NF-kB inhibitor protein), and B2R and
B3R genes (“Schaflen genes” family); (ii) structural and enzyme
proteins: ORF 103 (thymidine kinase), ORF 164 (ATPase/DNA
packaging protein), ORF 182 (thymidylate kinase), ORF 189
(hemagglutinin protein), and ORF 033 (complement control pro-
tein—B5R in VACV-Cop); and (iii) proteins recognized by the
immune system: ORF 099 (internal virion protein) and ORF 192
(serine-threonine kinase). Despite these polymorphisms, we con-
clude that these findings corroborate previous studies that showed
a close relationship between the Lister-derived strains in terms of
DNA and protein sequences, regardless of numerous historical
passages and maintenance of vaccine stocks.
Nucleotide sequence accession number. The genome se-
quence of VV strain Lister-Butantan was submitted to GenBank
with the accession no. KX061501.
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